Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02697877 · ClinicalTrials.gov registry record
Assessment of Global Myocardial Perfusion Reserve Using Coronary Sinus Flow Measurements
A clinical trial, sponsored by University of Illinois at Chicago.
- Completed
- Registry status
- 183
- Enrollment target
NCT02697877 is a clinical trial that has completed, run by University of Illinois at Chicago. The registered enrollment target is 183 participants.
The verdict
NCT02697877 has completed, sponsored by University of Illinois at Chicago.
- COMPLETED
- Registry status
- 183 participants
- Enrollment target
Study Summary
The aim of this study is to assess whether myocardial perfusion reserve, measured during routine clinically ordered regadenoson stress cardiac magnetic resonance (CMR) has prognostic value in predicting adverse cardiovascular events. Myocardial perfusion reserve will be measured with CMR by assessing blood flow through the coronary-sinus - the primary vein in the heart.
Interventions
- DRUG Regadenoson
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 183 participants |
| Start Date | 2016-02 |
| Est. Completion | 2018-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02697877
The ClinicalTrials.gov registry entry for NCT02697877 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 183 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Illinois at Chicago, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Regadenoson is the first listed.
NCT02697877 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02697877 about?
NCT02697877 is a clinical study titled "Assessment of Global Myocardial Perfusion Reserve Using Coronary Sinus Flow Measurements". The aim of this study is to assess whether myocardial perfusion reserve, measured during routine clinically ordered regadenoson stress cardiac magnetic resonance (CMR) has prognostic value in predicting adverse cardiovascular events. Myocardial perfusion reserve will be measured with CMR by assessin...
What is the current status of trial NCT02697877?
This trial is currently completed. The enrollment target is 183 participants. The study started on 2016-02. Estimated completion is 2018-07.
What interventions are being tested in trial NCT02697877?
The interventions under investigation include: Regadenoson (DRUG).
Who is sponsoring clinical trial NCT02697877?
This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.